Trump expands access to cannabis in a major shift in drug policy
PositiveWorld Affairs

- Former President Donald Trump has signed an executive order reclassifying cannabis to the same category as Tylenol with codeine, marking a significant shift in U.S. drug policy that has not seen such a change since 1971.
- This reclassification is expected to enhance access to cannabis for medical and recreational use, reflecting a growing acceptance of cannabis in American society and potentially influencing state-level regulations and market dynamics.
- The move contrasts sharply with Trump's previous actions, such as labeling fentanyl a 'weapon of mass destruction,' highlighting the complexities and evolving nature of drug policy in the U.S., where different substances are treated with varying degrees of severity.
— via World Pulse Now AI Editorial System



